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Abstract 
Background: To investigate the impacts of myomas on the outcomes of pregnancy in Iranian pregnant women with 
uterine fibroids. 
Materials and Methods: In this retrospective cohort study, the consequences of myomas on pregnancy were 
investigated in Iranian pregnant women referred to the perinatology clinic of Mahdieh Hospital (Tehran, Iran). 
One-hundred and sixty pregnant women diagnosed with uterine myoma were enrolled in the study as the case 
group. The control group consisted of 160 pregnant women without fibroma. The characteristics of the myomas 
and their relationships with pregnancy outcomes were surveyed. 
Results: Non-cephalic presentation, preterm labor, and Cesarean delivery were significantly higher in the case 
group in comparison with the control group. 106 patients (66.7%) had myomas larger than 5 cm in diameter. 
Intramural fibroids were seen in 132 (83%) patients. In addition, 133 (83.6%) patients had myomas in the body 
(corpus) of the uterus. Considering the number of myomas, 124 (78%) patients revealed one myoma in uterus. 
Uterine myomas during pregnancy rendered an important risk factor for cesarean delivery, breech presentation, 
and preterm delivery. However, there were no significant correlations between uterine myomas and IUGR, 
premature membranes rupture, either abortion or bleeding in the first trimester, low birth weight, and severe 
postpartum bleeding. 
Conclusion: Our results showed that the presence of myoma could modulate pregnancy outcomes. Our results 
can be useful in improving the quality of prenatal care and education. 
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Introduction 
Fibroids which occur in 20-60% of women in 
childbearing age are benign tumors of the smooth 
muscle of the uterus1. It is postulated; however, the 
actual incidence of fibroids is much higher as many 
patients remain asymptomatic and undiagnosed2. The 
prevalence of fibroids in pregnancy has been reported 
as 1.6% to 10.7 %. Higher incidences have been 
described in older and African-American women3. 
Several risk factors including advanced age, obesity, 
family history of uterine fibroids, hypertension and 
vitamin D deficiency have been described for uterine 
fibroids. Elevated progesterone and estrogen levels 
during pregnancy can increase uterine blood flow and 
the level of coupled gonadotropins modulating the risk 
of fibroids development4, 5. In symptomatic women, the 
most common presentation includes the pain resulted 
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from fibrillation degeneration. Other common 
symptoms include pelvic pain and vaginal bleeding6. 
Other complications associated with fibroids include 
abdominal pain, spontaneous abortion, fetal breech 
position, placental separation, premature rupture of 
the curtains, cesarean delivery, preterm delivery, 
severe postpartum hemorrhage and low-birth-weight7, 
8. The mechanisms by which fibroids lead to 
undesirable pregnancy outcomes seem to be 
multifactorial which are not clearly understood.  
Variabilities in the size, location, and type of fibroids 
make the survey on their impacts on pregnancy 
outcomes more difficult. Approximately 10% to 30% 
of women with uterine fibroids experience adverse 
complications during pregnancy9. However, the 
reports on these adverse effects have been limited due 
to selection bias, small and heterogeneous 
populations, variable inclusion criteria, the low 
occurrence of adverse outcomes, and inadequate 
controlling on confounding variables. Therefore, there 
have been inconsistent reports on the relationships 
between fibroids and adverse obstetric outcomes. 
Although decreased extensibility and mechanical 
obstruction of uterine may partly explain the 
pathogenesis of some adverse outcomes, the precise 
mechanisms by which uterine fibroids induce 
obstetric complications are obscure. So far, there are a 
few comprehensive studies on the fibroids associated 
with obstetric complications and their associations 
with pregnancy outcomes in Iranian women. This 
study aimed to investigate the impacts of uterine 
fibroids on pregnancy outcomes and their 
relationships with myomas in Iranian women. 
Methods 
Study design and participants: In this retrospective 
cohort study, the consequences of myomas on 
pregnancy were investigated in pregnant women 
referred to the perinatology clinic of Mahdieh 
Hospital (Tehran, Iran). Of the 5800 women referred 
for maternity care to the hospital from 2010 to 2018, 
784 were diagnosed with uterine fibroids. After 
excluding patients who did not fulfill the entry criteria, 
160 pregnant women diagnosed with uterine myomas 
via ultrasound during the first trimester of pregnancy 
were enrolled in the study as the case group. The 
control group consisted of 160 pregnant women 
without fibroma who were matched for maternal age 
and the number of pregnancies and deliveries (Ethic 
number: Ir. Sbmu. Msp. Rec. 1397.673).  
Inclusion and exclusion criteria: Inclusion criteria 
were the presence of at least one uterine myoma larger 
than 3 cm and singleton pregnancy. Exclusion criteria 
included histories of cesarean, myomectomy, removing 
the uterine septum, chronic uterine malfunction, 
cardiovascular or cerebrovascular diseases, diabetes, 
hypertension, kidney failure, hematological diseases, as 
well as the history of adverse outcomes (i.e. abortion, 
preterm labor, premature rupture of the curtains, 
intrauterine growth restriction (IUGR), intrauterine 
death, and placenta admission), ectopic pregnancies, 
embryonic uterine death, and embryonic anomalies.  
Data collection: The pregnancy complications 
including spontaneous abortion, non-cephalic 
presentation, premature rupture of the membranes, 
preterm delivery, cesarean delivery, severe postpartum 
bleeding (>500 ml in normal labor and >1000 ml in 
cesarean delivery), bleeding during the first trimester, 
IUGR and low-birth-weight were recorded for all the 
patients. The features of the myomas (i.e. type, size, 
number, and location), as well as their relationships 
with pregnancy outcomes, were assessed. Either the 
Chi-square test or Fisher's exact test was used to 
examine the relationship between the nominal 
variables. The data were analyzed using SPSS (v. 20.0) 
software. 
Results 
Comparison of Pregnancy outcomes between the 
study groups: The outcomes of pregnancy in the two 
studied groups summarized in table 1. According to 
these results, there were significant differences between 
the case and control groups considering the 
distributions of non-cephalic presentation preterm 
delivery (30.8% vs. 10.7% respectively) and Cesarean 
delivery (59.7% vs. 18.8% respectively). In the case 
group, 17 and 32 patients had deliveries at <34 weeks 
and between 34 to 37th weeks respectively. In 70% of 
the cases, preterm delivery was triggered by the onset 
of spontaneous contractions. Other outcomes did not 
show statistically significant differences between the 
studied groups.  
Characteristics of the myomas: According to the size, 
106 (66.7%) and 53 (33.3%) patients had myomas with 
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diameters of >5 cm and <5 cm respectively. In terms 
of the type of myomas, 132 (83%), 7 (4.4%), and 20 
(12.6%) patients represented with intramural fibroids, 
subserosal myoma, and submucosal myoma 
respectively. 
Considering the location, 133 (83.6%), 22 (13.8%), 
and 4 (2.5%) patients revealed the myomas in the 
body (corpus), fundus, and the lower segment of the 
uterus respectively. Finally, 124 (78%), 30 (18.9%), 
and 5 (3.1%) patients had one, two and three myomas 
respectively. 
Relationships between myomas features and 
pregnancy outcomes: There were significant 
associations between the size of myomas and 
spontaneous abortion (p=0.01), non-cephalic 
presentation (p=0.001), preterm delivery (p=0.001), 
Cesarean delivery (p=0.01), severe postpartum 
bleeding (p=0.01), and IUGR (p=0.001). In this 
regard, 87.5% of spontaneous abortions, 85.4% of 
non-cephalic presentations, 67.3% of preterm 
deliveries, 73.6% of Cesarean deliveries, 66.6% of 
severe postpartum bleedings, and 84.6% of IUGR 
cases occurred in women with myomas larger than 5 
cm. 
Significant relationships were found between the 
number of myomas and premature rupture of the 
membranes (p=0.03), preterm delivery (p=0.03), 
severe postpartum bleeding (p=0.001), and IUGR 
(p=0.02). Accordingly, 50% of the premature ruptures 
and all cases of severe postpartum bleeding and IUGR 
were encountered in patients with two or more myomas. 
On the other hand, 65.3% of preterm deliveries were 
observed in women with one myoma in their uterus. 
According to the type of myomas, significant 
associations were identified with preterm (p=0.01) and 
Cesarean (p=0.04) deliveries. In this regard, intramural 
fibroids were diagnosed in 100% and 77.7% of cases 
with preterm and cesarean deliveries respectively. 
Furthermore, there were significant relationships 
between the location of myomas and preterm (p=0.04) 
and Cesarean (p=0.02) deliveries. Accordingly, 97.9% 
and 78.9% of preterm and cesarean deliveries were seen 
in patients who had myomas in the body of their uterus 
here were no statistically significant relationships 
between the features of myomas and other pregnancy 
outcomes. 
Discussion 
Uterine fibroids have traditionally been considered as 
major contributors to adverse pregnancy outcomes. 
There are controversies about the impacts of fibroids on 
the outcomes of pregnancy before, either during or after 
delivery. The incidence of pregnancy complications 
such as spontaneous abortion, premature delivery, non-
Table 1: Comparison of Pregnancy outcomes between the studied groups. 
Outcome Study group P-value 
Case; N=frequency (%) Control; N=frequency (%) 
Spontaneous Abortion 8 (5 %) 5 (3.1 %) 0.66 
Non-cephalic presentation 48 (30.2 %) 11 (7.2 %) 0.00* 
Premature rupture of the 
membranes 
10 (6.3 %) 14 (8.8%) 0.81 
Preterm Delivery 49 (30.8%) 17 (10.7) 0.01* 
Cesarean Delivery 95 (59.7%) 30 (18.8%) 0.00* 
Severe Postpartum Bleeding 12 (7.5%) 6 (3.8%) 0.39 
First Trimester Bleeding 11 (6.9%) 14 (8.8%) 0.56 
IUGR 13 (8.2%) 17 (11.3%) 0.44 
Low birth weight (less than 2500 
grams) 
24 (15.2%) 22 (14.3%) 0.76 
*P value<0.05 considered significant 
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cephalic presentation, and severe bleeding has been 
related to the presence of myomas10. In some studies, 
the impacts of the size, number, and location of 
myomas have been shown on pregnancy outcomes11. 
Based on our results, uterine myomas during 
pregnancy were important risk factors for cesarean 
and preterm deliveries, as well as breech presentation. 
Nevertheless, no significant associations were 
detected between uterine myomas and IUGR, 
premature rupture of membranes, abortion and 
bleeding during the first trimester, low birth weight, 
and severe postpartum bleeding. 
In a study conducted by Coronado et al., preterm 
delivery was more frequently observed in women with 
uterine fibroids12. Nevertheless, Maryam 
Hashemnejad et al in Iran13 did not report any 
significant relationship between preterm delivery and 
uterine fibroids. Furthermore, we observed a higher 
incidence of premature delivery in women with large 
(> 5 cm diameter) fibroids. This observation can be 
partly explained by the lower potential for dislocation 
and higher susceptibility for irregular contractions in 
the uterine affected with myomas. Furthermore, it has 
been noted that reduced activity of oxytocinase 
enzyme in the urethra can lead to an elevated level of 
oxytocin and subsequently the early onset of 
contractions in women with uterus myomas. 
In the present study, the prevalence of cesarean 
delivery was significantly higher in women who 
suffered from large (i.e. > 5 cm diameter) intramural 
myomas than those without fibroma (59.7% vs. 18.8% 
respectively). This observation was consistent with 
the findings of Hashemnejad et al13. 
Conclusion 
Our results showed that the presence of uterine 
myomas could affect some pregnancy-related 
outcomes. Our results can be useful for improving the 
quality of prenatal care and education. It is 
recommended to provide necessary measures (e.g. 
possible preterm or cesarean deliveries) for pregnant 
women with uterine myomas. Further studies are 
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